Plata-Salamán C R, Sonti G, Borkoski J P
School of Life and Health Sciences, University of Delaware, Newark 19716, USA.
Am J Physiol. 1995 Jun;268(6 Pt 2):R1513-9. doi: 10.1152/ajpregu.1995.268.6.R1513.
Increased levels of beta 2-microglobulin (part of the class I major histocompatibility complex molecules) in body fluids are associated with activation of the immune system and pathophysiological processes. Various anorexigenic cytokines, including interferon-gamma and tumor necrosis factor-alpha, induce the expression of class I molecules. Therefore, it is possible that beta 2-microglobulin may participate in the feeding suppression induced by cytokines or may have direct effects on feeding. In the present study, the effects of beta 2-microglobulin on the central regulation of feeding were investigated. Intracerebroventricular (ICV) microinfusion of beta 2-microglobulin (0.01-5.0 micrograms/rat) suppressed the nighttime food intake dose dependently. The most effective dose of beta 2-microglobulin, 5.0 micrograms/rat, decreased nighttime feeding by 38% and total daily food intake by 28%. Computerized analysis of behavioral patterns demonstrated that beta 2-microglobulin decreased meal size and meal frequency during the initial 4-h interval, but decreased only meal size during the second 4-h interval after the ICV microinfusion of 5.0 micrograms beta 2-microglobulin/rat; meal duration was not significantly affected in any interval. For the complete nighttime period, only meal size was significantly decreased. Cerebrospinal fluid-brain and rectal temperatures did not change significantly. ICV microinfusion of heat-treated beta 2-microglobulin or intraperitoneal administration of beta 2-microglobulin, in doses equivalent to those administered centrally, had no effect on food intake. The results suggest that beta 2-microglobulin may act centrally to decrease feeding, and this effect may participate in the anorexia frequently accompanying pathological processes.
体液中β2-微球蛋白(I类主要组织相容性复合体分子的一部分)水平升高与免疫系统激活及病理生理过程相关。包括γ干扰素和肿瘤坏死因子-α在内的多种厌食性细胞因子可诱导I类分子的表达。因此,β2-微球蛋白有可能参与细胞因子诱导的摄食抑制,或对摄食有直接影响。在本研究中,研究了β2-微球蛋白对摄食中枢调节的影响。脑室内(ICV)微量注射β2-微球蛋白(0.01 - 5.0微克/大鼠)剂量依赖性地抑制夜间食物摄入量。β2-微球蛋白最有效的剂量,即5.0微克/大鼠,使夜间摄食量减少38%,每日总食物摄入量减少28%。行为模式的计算机分析表明,在最初的4小时内,β2-微球蛋白减少了餐量和进餐频率,但在脑室内微量注射5.0微克β2-微球蛋白/大鼠后的第二个4小时内仅减少了餐量;在任何时间段内进餐持续时间均未受到显著影响。对于整个夜间时段,只有餐量显著减少。脑脊液-脑和直肠温度没有明显变化。脑室内微量注射热处理过的β2-微球蛋白或腹腔注射与脑室内注射等效剂量的β2-微球蛋白对食物摄入量没有影响。结果表明,β2-微球蛋白可能通过中枢作用减少摄食,且这种作用可能参与了病理过程中常伴随的厌食症。